Antibiofilm high oxidation state silver periodates for agricultural use
Innovotech Labs introduces silver(III) periodates as effective microbicides for agriculture, offering rapid action against plant pathogens with minimal environmental impact. These compounds show stability and potential as sustainable alternatives to antibiotics.
Overview
Innovotech Labs Corporation has developed a breakthrough solution in the form of silver(III) periodates for agricultural applications. These compounds serve as effective, broad-spectrum microbicides capable of eliminating plant pathogens through seed treatments and foliar sprays. Their unique formulation combines silver and iodine to not only combat mature biofilms and planktonic microorganisms but also to minimize the development of microbial resistance. With their high stability and low effective concentrations, silver(III) periodates present an economical and environmentally friendly alternative to traditional antibiotic-based treatments.
Technical specifications
Key features:
- Antimicrobial Action: Effective against a wide range of plant pathogens, eliminating biofilms and planktonic forms.
- Stability: Silver(III) periodates exhibit high stability, reducing the risk of compound inactivation and ensuring a longer shelf life.
- Mechanism of Action: The combination of silver and iodine reduces the potential for developing microbial resistance.
- Economic Efficiency: Effective at sub-cytotoxic concentrations, keeping costs competitive and environmentally safe.
Technology readiness level
The technology is currently at a Technology Readiness Level (TRL) of 4. Initial testing has demonstrated promising antimicrobial properties in vitro and in preliminary greenhouse and field studies. Ongoing efforts focus on further characterization and development of scalable manufacturing processes. Select products will undergo pilot testing in relevant agricultural scenarios to validate their effectiveness and facilitate collaboration for product registration.
About Innovotech Labs Corporation
Innovotech Labs Corporation is a contract research organization and a wholly owned subsidiary of the diversified Canadian technology company Innovotech Inc. The organization provides specialized laboratory services, including proprietary devices for antimicrobial testing designed for applications such as medical devices like catheters, implants, and wound dressings. Beyond testing, the company is involved in commercializing antimicrobial silver solutions, including the development of silver compounds like InnovoSIL-1. In January 2026, the company amalgamated with Keystone Labs Inc. to form a single entity, continuing to operate as Innovotech Labs Corporation under the broader Innovotech Inc. corporate structure, which is listed on the TSX Venture Exchange.
These services and products are essential for medical device manufacturers and industrial clients needing to navigate evolving international regulatory standards regarding biofilm formation, proliferation, and microbial translocation. By providing specialized technical expertise and developing innovative antimicrobial solutions, the company assists clients in reducing infections and improving health outcomes. Their laboratory operations are accredited to ISO/IEC 17025:2017 standards, ensuring technical competence for their defined scope of services. The company also engages in research and development supported by government initiatives, such as the NRC IRAP, to expand its technical capabilities and address complex challenges in antimicrobial product development.
Inquire about this partnering listing
Industry applications
delivered to your inbox.